NCT02513992

Brief Summary

Ictal SPECT with intravenous injection in a cubital vein of a perfusion tracer is an established technique to localize the ictal onset zone during presurgical evaluation of refractory focal epilepsy. When seizures last less than 10 seconds, localizing information is often not obtained. Since it takes around 30 seconds before the tracer reaches the brain after intravenous injection, ictal hyperperfusion most likely has already switched to postictal hypoperfusion. In this study, we plan to inject the perfusion tracer in the aorta proximal to the cerebral arteries, which will allow a true ictal injection in patients with seizures of short duration.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 3, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

September 18, 2020

Status Verified

September 1, 2020

Enrollment Period

2.2 years

First QC Date

July 19, 2015

Last Update Submit

September 17, 2020

Conditions

Keywords

ictal SPECT

Outcome Measures

Primary Outcomes (1)

  • Correct localization of the ictal onset zone

    seizure free outcome will be assessed 1 year after epilepsy surgery and correlated with Subtracted ictal SPECT co-registered with MRI (SISCOM) results

    1 year after epilepsy surgery

Study Arms (1)

intra-arterial injection of tracer

EXPERIMENTAL

The perfusion tracer 99m-Technetium Ethyl Cysteinate Dimer will be injected via an intra-arterial catheter by a pressure injector to obtain a subtracted ictal SPECT co-registered with MRI (SISCOM)

Procedure: intra-arterial injection of tracerDrug: 99m-Technetium Ethyl Cysteinate DimerDevice: intra-arterial catheterDevice: pressure injector

Interventions

intra-arterial ictal injection of perfusion tracer

intra-arterial injection of tracer

administration of perfusion tracer 99m Tc-ECD during epileptic seizure

Also known as: 99m Tc-ECD
intra-arterial injection of tracer

placement of intra-arterial catheter via femoral artery

intra-arterial injection of tracer

the injection of the perfusion tracer will be delivered with a pressure injector

intra-arterial injection of tracer

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Refractory unifocal epilepsy
  • Early ictal SPECT with intravenous injection did not localize the ictal onset zone
  • Several seizure per day, or clusters of several seizures per day
  • Seizures are of short duration (i.e. less than 10-15 seconds)
  • Patient asks for epilepsy surgery

You may not qualify if:

  • Renal failure
  • Allergy to contrast agents
  • Fever
  • Anemia
  • Usage of anticoagulants
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Leuven, department of Neurology

Leuven, 3000, Belgium

Location

Related Publications (6)

  • Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain. 2003 May;126(Pt 5):1103-11. doi: 10.1093/brain/awg108.

    PMID: 12690050BACKGROUND
  • Van Paesschen W. Ictal SPECT. Epilepsia. 2004;45 Suppl 4:35-40. doi: 10.1111/j.0013-9580.2004.04008.x.

    PMID: 15281956BACKGROUND
  • Van Paesschen W, Dupont P, Sunaert S, Goffin K, Van Laere K. The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol. 2007 Apr;20(2):194-202. doi: 10.1097/WCO.0b013e328042baf6.

    PMID: 17351491BACKGROUND
  • Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W. Neuronuclear assessment of patients with epilepsy. Semin Nucl Med. 2008 Jul;38(4):227-39. doi: 10.1053/j.semnuclmed.2008.02.004.

    PMID: 18514079BACKGROUND
  • Tousseyn S, Dupont P, Goffin K, Sunaert S, Van Paesschen W. Correspondence between large-scale ictal and interictal epileptic networks revealed by single photon emission computed tomography (SPECT) and electroencephalography (EEG)-functional magnetic resonance imaging (fMRI). Epilepsia. 2015 Mar;56(3):382-92. doi: 10.1111/epi.12910. Epub 2015 Jan 29.

    PMID: 25631544BACKGROUND
  • Cleeren E, Casteels C, Goffin K, Janssen P, Van Paesschen W. Ictal perfusion changes associated with seizure progression in the amygdala kindling model in the rhesus monkey. Epilepsia. 2015 Sep;56(9):1366-75. doi: 10.1111/epi.13077. Epub 2015 Jul 15.

    PMID: 26174547BACKGROUND

MeSH Terms

Conditions

Epilepsy

Interventions

technetium Tc 99m bicisate

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Wim Van Paesschen, MD PhD

    UZ Leuven/KU Leuven

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

July 19, 2015

First Posted

August 3, 2015

Study Start

May 1, 2016

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

September 18, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

Locations